Scalper1 News
KaloBios Pharmaceuticals (KBIO) CEO Martin Shkreli was arrested on charges of securities fraud Thursday, sending KaloBios stock down more than 50% in premarket before trading was halted. The FBI detained Shkreli on charges that he’d deceived investors in his former hedge fund MSMB Capital Management about the performance of the fund, and paid their supposed returns with funds from Retrophin (RTRX), a biotech company that he headed until the board Scalper1 News
Scalper1 News